Brincidofovir Approval Status
FDA Approved: No
Generic name: brincidofovir
Company: Chimerix, Inc.
Treatment for: Ebola Virus Disease
Brincidofovir is a nucleotide analog broad-spectrum antiviral under FDA review to assess the safety and efficacy in patients with confirmed Ebola virus infection.
Development Status and FDA Approval Process for brincidofovir
|Nov 13, 2014||Chimerix's Brincidofovir Selected for Use in Ebola Clinical Trial in West Africa|
|Oct 6, 2014||Chimerix Announces Emergency Investigational NDA for Brincidofovir Authorized by FDA for Patients With Ebola Virus Disease|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.